Trioxacarcin A, bound form
[(2S,3R,4R,6R)-6-[[(1S,8S,10S,17S,18S,19R,21S)-17-[(2S,4R,5S,6S)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy-19-(dimethoxymethyl)-10,13,18-trihydroxy-6-methoxy-3,18-dimethyl-11-oxo-16,20,22-trioxahexacyclo[17.2.1.02,15.05,14.07,12.017,21]docosa-2(15),3,5(14),6,12-pentaen-8-yl]oxy]-4-hydroxy-2,4-dimethyloxan-3-yl] acetate
Molecular Identity
Trioxacarcin A, bound form
[(2S,3R,4R,6R)-6-[[(1S,8S,10S,17S,18S,19R,21S)-17-[(2S,4R,5S,6S)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy-19-(dimethoxymethyl)-10,13,18-trihydroxy-6-methoxy-3,18-dimethyl-11-oxo-16,20,22-trioxahexacyclo[17.2.1.02,15.05,14.07,12.017,21]docosa-2(15),3,5(14),6,12-pentaen-8-yl]oxy]-4-hydroxy-2,4-dimethyloxan-3-yl] acetate
PubChem CID: 24801861
2D Structure
Properties
C42H54O20
Molecular Formula
878.90
Molecular Weight
g/mol
878.3208
Exact Mass
Da
0.4
XLogP
Drug-like (Lipinski: < 5)
274
TPSA
May have limited oral absorption
6
H-Bond Donors
20
H-Bond Acceptors
1750
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(3)
Trioxacarcin A, bound formJOCGGT
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Trioxacarcin A, bound form
Loading drug network...